The Association for Accessible Medicines is a national trade group that represents generic drug makers in the United States. It lobbies Congress on health and drug competition issues, including patent disputes, patent review processes, and laws affecting drug supply and market competition. Filings show work on specific bills such as S. 1096 and S. 1041 and spending reported through January 2026.
Show the dominant industry call, how mixed the client looks, and the allocation across the top labeled sectors.
Annual totals based on disclosed filing amounts.
Issue rankings are based on disclosed activity mentions, with filing amounts apportioned evenly across issues within the same filing.
The lobbying registrants handling this client, ranked by disclosed filing amounts.
Lobbyists are ranked by appearances and an equal share of each filing's reported amount.
mr JOSEPH H GIBSON
The latest disclosures for this client.
THE GIBSON GROUP, LLC
Q1THE GIBSON GROUP, LLC
Q4The entities named in disclosed activities are the clearest available signal for where the client is aiming attention.
THE GIBSON GROUP, LLC
THE GIBSON GROUP, LLC
Q3THE GIBSON GROUP, LLC
Q2THE GIBSON GROUP, LLC
Q1